Search

Veera Hanuman Konda

from Concord, NC
Age ~37
Get Report
Also known as:
Veera Hanuman Prasad Konda, Veera R Konda, M Konda, P Konda, Hanaman A, N A
Related to:
Maheswarudu Gadekari Konda
Connected to:
Laura R Konda, 43Leonard F Konda, 85Nagaraj Konda, 44Neal J Konda, 38Santhosh K Konda, 39Sathish Konda, 40Sunil K Konda, 45Vijith R Konda, 52Srikanth Kondagunta, 53Marinela Kondakciu, 37

Veera Konda Phones & Addresses

  • Concord, NC
  • Charlotte, NC
  • Fremont, CA
  • Bellevue, WA
  • Newcastle, WA
  • La Palma, CA
  • Glen Carbon, IL
  • Newcastle, WA
  • Edwardsville, IL

Publications

Us Patents

Xanthohumol And Tetrahydro-Isoalpha Acid Based Protein Kinase Modulation Cancer Treatment

View page
US Patent:
7736677, Jun 15, 2010
Filed:
Jun 20, 2007
Appl. No.:
11/820568
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Veera Konda - Gig Harbor WA, US
Amy Hall - Gig Harbor WA, US
Linda M. Pacioretty - Brooktondale NY, US
Anu Desai - Gig Harbor WA, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.

Treatment Modalities For Autoimmune Diseases

View page
US Patent:
7901714, Mar 8, 2011
Filed:
Jan 4, 2007
Appl. No.:
11/649584
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
Jeffrey S. Bland - Fox Island WA, US
Robert Lerman - Gig Harbor WA, US
Amy J. Hall - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Anu Desai - Gig Harbor WA, US
Assignee:
Metaproteomics, LLP - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.

Methods And Compositions For Heavy Metal Detoxification

View page
US Patent:
8241674, Aug 14, 2012
Filed:
Feb 13, 2008
Appl. No.:
12/030335
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Amy Hall - Gig Harbor WA, US
Anu Desai - Gig Harbor WA, US
Jeffrey S. Bland - Fox Island WA, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A61K 33/30
A61P 43/00
US Classification:
424641, 514823, 514423, 514 187, 424756, 424725, 424750
Abstract:
Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.

Protein Kinase Modulation By Hops And Products

View page
US Patent:
8263139, Sep 11, 2012
Filed:
Aug 9, 2006
Appl. No.:
11/501393
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Linda M. Pacioretty - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Amy J. Hall - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Anu Desai - Gig Harbor WA, US
Assignee:
Metaproteonics, LLC - San Clemente CA
International Classification:
A61K 36/00
US Classification:
424725, 424779
Abstract:
Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or.

Cis 3,4-Dihydroxy-2-(3-Methylbutanoyl)-5-(3-Methylbutyl)-4-(4-Methylpentanoyl)Cyclopent-2-En-1-Derivatives, Substantially Enantiomerically Pure Compositions And Methods

View page
US Patent:
8410178, Apr 2, 2013
Filed:
Oct 28, 2011
Appl. No.:
13/284852
Inventors:
Brian J. Carroll - Gig Harbor WA, US
Gary Darland - Gig Harbor WA, US
Anuradha Desai - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Clinton J. Dahlberg - Port Orchard WA, US
Jan Urban - Gig Harbor WA, US
Assignee:
KinDex Therapeutics, LLC - Seattle WA
International Classification:
A61K 31/12
C07C 49/00
US Classification:
514690, 568379
Abstract:
The present application provides cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives and substantially enantiomerically pure compositions thereof. These derivatives include (+)-(4S,5R)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, (−)-(4R,5S)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, and salts and crystals thereof. The application further provides methods of using the disclosed compounds and compositions to activate PPARγ, activate GPR120, inhibit inflammation, and treat conditions responsive to PPARγ modulation, conditions responsive to GPR120 modulation, and metabolic disturbances such as diabetes.

Cis, 3,4-Dihydroxy-2-(3-Methylbutanoyl)-5-(3-Methylbutyl)-4-(4-Methylpentanoyl)Cyclopent-2-En-1-Derivatives, Substantially Enantiomerically Pure Compositions And Methods

View page
US Patent:
8410179, Apr 2, 2013
Filed:
Mar 14, 2012
Appl. No.:
13/420062
Inventors:
Brian J. Carroll - Gig Harbor WA, US
Gary Darland - Gig Harbor WA, US
Anuradha Desai - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Clinton J. Dahlberg - Port Orchard WA, US
Jan Urban - Gig Harbor WA, US
Assignee:
KinDex Therapeutics, LLC - Seattle WA
International Classification:
A61K 31/12
C07C 49/00
US Classification:
514690, 568379
Abstract:
The present application provides cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives and substantially enantiomerically pure compositions thereof. These derivatives include (+)-(4S,5R)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, (−)-(4R,5S)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, and salts and crystals thereof. The application further provides methods of using the disclosed compounds and compositions to activate PPARγ, activate GPR120, inhibit inflammation, and treat conditions responsive to PPARγ modulation, conditions responsive to GPR120 modulation, and metabolic disturbances such as diabetes.

Methods And Compositions For Heavy Metal Detoxification

View page
US Patent:
8475850, Jul 2, 2013
Filed:
Jan 18, 2012
Appl. No.:
13/352831
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Amy J. Hall - Gig Harbor WA, US
Anu Desai - Gig Harbor WA, US
Jeffrey S. Bland - Fox Island WA, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A61K 36/18
A61K 33/30
A61K 31/44
A61K 31/15
A61P 43/00
US Classification:
424725, 424641, 514334, 514640
Abstract:
Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.

Anti-Inflammatory Botanical Products For The Treatment Of Metabolic Syndrome And Diabetes

View page
US Patent:
8206753, Jun 26, 2012
Filed:
Dec 7, 2006
Appl. No.:
11/635305
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Amy J. Hall - Gig Harbor WA, US
Veera Konda - Gig Harbor WA, US
Linda M. Pacioretty - Brooktondale NY, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs.
Control profile
Veera Hanuman Konda from Concord, NC, age ~37 Get Report